Literature DB >> 19200621

Serum albumin in risk assessment for Clostridium difficile.

D M Anthony, T Reynolds, J Paton, L Rafter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19200621     DOI： 10.1016/j.jhin.2008.12.003

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  3 in total

Review 1.  Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.

Authors:  Stefano Di Bella; Paolo Ascenzi; Steven Siarakas; Nicola Petrosillo; Alessandra di Masi
Journal:  Toxins (Basel)       Date:  2016-05-03       Impact factor: 4.546

2.  Are Antimotility Agents Safe for Use in Clostridioides difficile Infections? Results From an Observational Study in Malignant Hematology Patients.

Authors:  Carla Kuon; Rae Wannier; David Sterken; Margaret C Fang; Jeffrey Wolf; Priya A Prasad
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-11-05

3.  Derivation and validation of a simple, accurate and robust prediction rule for risk of mortality in patients with Clostridium difficile infection.

Authors:  Emma Butt; Jane A H Foster; Edward Keedwell; Julia E A Bell; Richard W Titball; Aneel Bhangu; Stephen L Michell; Ray Sheridan
Journal:  BMC Infect Dis       Date:  2013-07-12       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.